The Food and Drug Administration has made a significant dent in its large backlog of generic drug applications thanks to amendments to last year's reauthorization of the Prescription Drug User Fee Act, the agency said.
With some studies showing that patients' failure to take their medications as directed costs the economy nearly $300 billion per year, one group is looking to tackle what it sees as part of the problem: doctors' and pharmacists' instructions to patients on how much medicine to take and when.
More than half of the estimated 5.4 million Americans with Alzheimer's disease and other forms of dementia are at risk of wandering and becoming lost, according to the National Institute on Aging, a figure that has prompted the federal government to develop a series of training videos for police.
Amid mounting evidence of the negative clinical and economic consequences of medication nonadherence, research featured on the cover of this month’s Health Affairs breaks new ground by urging innovative approaches to improve medication adherence and to “achieve a higher-performing health system.”
The Obama administration's delay in implementing a key healthcare provision in 2014 only serves to add confusion around the overall package, especially as individuals will still be required to buy health insurance or pay a penalty, Mac Crawford, Crawford Ross partner and former CVS Caremark chairman, told Benzinga.
Oregon Gov. John Kitzhaber, a Democrat, has signed what the National Association of Community Pharmacy has characterized as groundbreaking reform legislation that applies reasonable standards to how pharmacy benefit managers audit community pharmacies, provides increased transparency into generic prescription drug reimbursement and ensures that PBM administrators of prescription drug claims are registered within the state.
Sandoz has started a late-stage clinical trial of a biosimilar version of a drug used to treat autoimmune disorders, hoping the results will support its efforts to win regulatory approval in the United States and Europe.
As new state legislation takes effect Monday to help bring greater patient access to vaccines, Walgreens has significantly expanded vaccine availability at all of its 204 locations across Indiana, the retailer announced.